Analyze Diet
BMC research notes2018; 11(1); 672; doi: 10.1186/s13104-018-3776-9

Does BMP2 play a role in the pathogenesis of equine degenerative suspensory ligament desmitis?

Abstract: Horses afflicted with degenerative suspensory ligament desmitis (DSLD) suffer from progressive leg pain and lameness without history of trauma. DSLD is a systemic disorder caused by abnormal accumulation of proteoglycans in many connective tissues. One proteoglycan found in higher quantities in DSLD is decorin. The accumulated decorin has an abnormally glycosylated glycosaminoglycan chain in DSLD. In addition to acellular accumulations of proteoglycans foci of active fibroblasts/tenoblasts were observed in some tendons and suspensory ligaments (SLs) from DSLD cases We have hypothesized that this represents an early event in DSLD and that production of chondrogenic growth factors, such as BMP2, and/or enzyme participating in glycosylation of glycosaminoglycans is a major factor in initiation and progression of DSLD. Results: Using immunohistochemistry we have identified BMP2 in these cellular foci, indicating association with proteoglycan production, but not in other cells in the tendon and SLs. In contrast, very little staining for TGFβ and dermatan sulfate epimerase, an enzyme involved in glycosylation of glycosaminoglycan chains, was observed in these foci and other cells in both control and DSLD-affected tendons and SLs. Our data support our hypothesis that chondrogenic growth factors may be responsible, at least in part for progression of DSLD in horses.
Publication Date: 2018-09-18 PubMed ID: 30227887PubMed Central: PMC6145121DOI: 10.1186/s13104-018-3776-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers are investigating the potential role of a specific growth factor, BMP2, in the development and progression of a painful and debilitating condition affecting horses, known as DSLD.

Study Overview

The study in question is exploring the involvement of Bone Morphogenetic Protein 2 (BMP2) in the cause and progression of a degenerative condition seen in horses, Degenerative Suspensory Ligament Desmitis (DSLD). The condition causes progressive pain and immobility in the affected horse, and it isn’t related to any traumatic events. DSLD is known to be a systemic issue arising from the abnormal accumulation of certain proteins, known as proteoglycans, in various connective tissues within the horse’s body.

  • The researchers studied the role of specific proteoglycans, particularly one called decorin, which they found in higher quantities in DSLD cases. The disorder caused an abnormal modification, or glycosylation, of glycosaminoglycan chains connected with decorin.
  • Apart from the accumulation of proteoglycans, the research team observed areas of active fibroblasts and tenoblasts in some tendons and suspensory ligaments from DSLD-infected horses, suggesting this may be an early sign of the condition.

The team hypothesized that the production of chondrogenic growth factors, such as BMP2, and/or an enzyme involved in altering the structure of glycosaminoglycans, is a crucial factor in initiating and furthering the DSLD condition.

Results and Conclusion

To verify their hypothesis, researchers used immunohistochemistry, a laboratory process used to visually localize proteins in cells of a tissue section.

  • They were able to identify BMP2 in the active cellular areas, suggesting a link to proteoglycan production. However, BMP2 was not found within other cells of the tendon and suspensory ligaments.
  • Significantly less staining (meaning less of the substance was found) for Transforming Growth Factor beta (TGFβ) and dermatan sulfate epimerase – the enzyme involved in glycosylation of glycosaminoglycan chains – was found, both in the active cellular regions and other cells, in both DSLD-affected and control tendons and suspensory ligaments.

The obtained results suggest that chondrogenic growth factors, such as BMP2, could be partially responsible for the development and progression of DSLD in horses, thereby supporting the initial hypothesis of the researchers.

Cite This Article

APA
Young M, Moshood O, Zhang J, Sarbacher CA, Mueller POE, Halper J. (2018). Does BMP2 play a role in the pathogenesis of equine degenerative suspensory ligament desmitis? BMC Res Notes, 11(1), 672. https://doi.org/10.1186/s13104-018-3776-9

Publication

ISSN: 1756-0500
NlmUniqueID: 101462768
Country: England
Language: English
Volume: 11
Issue: 1
Pages: 672
PII: 672

Researcher Affiliations

Young, Madeline
  • Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.
Moshood, Olaniyi
  • Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.
Zhang, Jian
  • Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.
Sarbacher, Carolyn A
  • Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.
Mueller, P O Eric
  • Department of Large Animal Medicine, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.
Halper, Jaroslava
  • Department of Pathology, College of Veterinary Medicine, AU/UGA Medical Partnership, The University of Georgia, Athens, GA, 30602, USA. jhalper@uga.edu.

MeSH Terms

  • Animals
  • Arthritis
  • Bone Morphogenetic Protein 2 / physiology
  • Female
  • Horse Diseases / physiopathology
  • Horses
  • Ligaments
  • Male
  • Tendons
  • Transforming Growth Factor beta / physiology

References

This article includes 17 references
  1. Mero JL, Pool R. Twenty cases of degenerative suspensory ligament desmitis in Peruvian Paso horses. In: Proceedings, annual convention of AAEP 2002; Orlando.
  2. Young JH. Degenerative suspensory ligament desmitis. Hoofcare Lameness 1993;6:19.
  3. Halper J, Kim B, Khan A, Yoon JH, Mueller PO. Degenerative suspensory ligament desmitis as a systemic disorder characterized by proteoglycan accumulation.. BMC Vet Res 2006 Apr 12;2:12.
    doi: 10.1186/1746-6148-2-12pmc: PMC1459153pubmed: 16611357google scholar: lookup
  4. Halper J, Khan A, Mueller POE. Degenerative suspensory ligament desmitis—a new reality. Pak Vet J 2011;31(1):1–8.
  5. Kim B, Yoon JH, Zhang J, Eric Mueller PO, Halper J. Glycan profiling of a defect in decorin glycosylation in equine systemic proteoglycan accumulation, a potential model of progeroid form of Ehlers-Danlos syndrome.. Arch Biochem Biophys 2010 Sep 15;501(2):221-31.
    doi: 10.1016/j.abb.2010.06.017pubmed: 20599673google scholar: lookup
  6. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.. J Cell Biol 1997 Feb 10;136(3):729-43.
    doi: 10.1083/jcb.136.3.729pmc: PMC2134287pubmed: 9024701google scholar: lookup
  7. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.. Crit Rev Biochem Mol Biol 1997;32(2):141-74.
    pubmed: 9145286doi: 10.3109/10409239709108551google scholar: lookup
  8. Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.. Matrix Biol 2015 Mar;42:11-55.
  9. Scarfì S. Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair.. World J Stem Cells 2016 Jan 26;8(1):1-12.
    doi: 10.4252/wjsc.v8.i1.1pmc: PMC4723717pubmed: 26839636google scholar: lookup
  10. Cicione C, Muiños-López E, Hermida-Gómez T, Fuentes-Boquete I, Díaz-Prado S, Blanco FJ. Alternative protocols to induce chondrogenic differentiation: transforming growth factor-β superfamily.. Cell Tissue Bank 2015 Jun;16(2):195-207.
    doi: 10.1007/s10561-014-9472-7pubmed: 25204398google scholar: lookup
  11. Li J, Dong S. The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation.. Stem Cells Int 2016;2016:2470351.
    pmc: PMC5198191pubmed: 28074096doi: 10.1155/2016/2470351google scholar: lookup
  12. Tiedemann K, Larsson T, Heinegård D, Malmström A. The glucuronyl C5-epimerase activity is the limiting factor in the dermatan sulfate biosynthesis.. Arch Biochem Biophys 2001 Jul 1;391(1):65-71.
    doi: 10.1006/abbi.2001.2376pubmed: 11414686google scholar: lookup
  13. Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M, Westergren-Thorsson G, Malmström A. Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes.. Glycobiology 2005 Dec;15(12):1277-85.
    doi: 10.1093/glycob/cwj027pubmed: 16118286google scholar: lookup
  14. Maccarana M, Kalamajski S, Kongsgaard M, Magnusson SP, Oldberg A, Malmström A. Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.. Mol Cell Biol 2009 Oct;29(20):5517-28.
    doi: 10.1128/MCB.00430-09pmc: PMC2756890pubmed: 19687302google scholar: lookup
  15. Halper J. Growth factors as active participants in carcinogenesis: a perspective.. Vet Pathol 2010 Jan;47(1):77-97.
    doi: 10.1177/0300985809352981pubmed: 20080487google scholar: lookup
  16. Rui YF, Lui PP, Wong YM, Tan Q, Chan KM. BMP-2 stimulated non-tenogenic differentiation and promoted proteoglycan deposition of tendon-derived stem cells (TDSCs) in vitro.. J Orthop Res 2013 May;31(5):746-53.
    doi: 10.1002/jor.22290pubmed: 23238867google scholar: lookup
  17. Luo W, Sandy J, Trella K, Gorski D, Gao S, Li J, Brounts S, Galante J, Plaas A. Degenerative Suspensory Ligament Desmitis (DSLD) in Peruvian Paso Horses Is Characterized by Altered Expression of TGFβ Signaling Components in Adipose-Derived Stromal Fibroblasts.. PLoS One 2016;11(11):e0167069.

Citations

This article has been cited 9 times.
  1. Momen M, Brauer K, Patterson MM, Sample SJ, Binversie EE, Davis BW, Cothran EG, Rosa GJM, Brounts SH, Muir P. Genetic architecture and polygenic risk score prediction of degenerative suspensory ligament desmitis (DSLD) in the Peruvian Horse. Front Genet 2023;14:1201628.
    doi: 10.3389/fgene.2023.1201628pubmed: 37645058google scholar: lookup
  2. Roberts JH, Zhang J, David F, McLean A, Blumenshine K, Müller-Alander E, Halper J. Expression of genes with biomarker potential identified in skin from DSLD-affected horses increases with age. PLoS One 2023;18(7):e0287740.
    doi: 10.1371/journal.pone.0287740pubmed: 37450486google scholar: lookup
  3. Momen M, Brounts SH, Binversie EE, Sample SJ, Rosa GJM, Davis BW, Muir P. Selection signature analyses and genome-wide association reveal genomic hotspot regions that reflect differences between breeds of horse with contrasting risk of degenerative suspensory ligament desmitis. G3 (Bethesda) 2022 Sep 30;12(10).
    doi: 10.1093/g3journal/jkac179pubmed: 35866615google scholar: lookup
  4. Roberts JH, Halper J. Connective Tissue Disorders in Domestic Animals. Adv Exp Med Biol 2021;1348:325-335.
    doi: 10.1007/978-3-030-80614-9_15pubmed: 34807427google scholar: lookup
  5. Haythorn A, Young M, Stanton J, Zhang J, Mueller POE, Halper J. Differential gene expression in skin RNA of horses affected with degenerative suspensory ligament desmitis. J Orthop Surg Res 2020 Oct 7;15(1):460.
    doi: 10.1186/s13018-020-01994-ypubmed: 33028365google scholar: lookup
  6. Kram V, Shainer R, Jani P, Meester JAN, Loeys B, Young MF. Biglycan in the Skeleton. J Histochem Cytochem 2020 Nov;68(11):747-762.
    doi: 10.1369/0022155420937371pubmed: 32623936google scholar: lookup
  7. Zappia J, Joiret M, Sanchez C, Lambert C, Geris L, Muller M, Henrotin Y. From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues. Biomolecules 2020 Jan 3;10(1).
    doi: 10.3390/biom10010080pubmed: 31947880google scholar: lookup
  8. Ribitsch I, Gueltekin S, Keith MF, Minichmair K, Peham C, Jenner F, Egerbacher M. Age-related changes of tendon fibril micro-morphology and gene expression. J Anat 2020 Apr;236(4):688-700.
    doi: 10.1111/joa.13125pubmed: 31792963google scholar: lookup
  9. Guest DJ, Birch HL, Thorpe CT. A review of the equine suspensory ligament: Injury prone yet understudied. Equine Vet J 2025 Sep;57(5):1167-1182.
    doi: 10.1111/evj.14447pubmed: 39604165google scholar: lookup